Nina Boulman

No ORCID on file · 1 paper in corpus
observational 2011
Gonadotropin releasing hormone agonists may minimize cyclophosphamide associated gonadotoxicity in SLE and autoimmune diseases
Seminars in arthritis and rheumatism ·doi:10.1016/j.semarthrit.2011.05.008

OBJECTIVE: Since young women undergoing cyclophosphamide pulse therapy may suffer premature ovarian failure (POF) in almost 50% of cases, we examined the ability of GnRH-a administration to minimize the gonadotoxicity associated with cyclop…